ONTOLOGY REPORT - ANNOTATIONS
Term: Cervical Intraepithelial Neoplasia
Accession: RDO:0007165
browse the term
Definition: A malignancy arising in uterine cervical epithelium and confined thereto, representing a continuum of histological changes ranging from well-differentiated CIN 1 (formerly, mild dysplasia) to severe dysplasia/carcinoma in situ, CIN 3. The lesion arises at the squamocolumnar cell junction at the transformation zone of the endocervical canal, with a variable tendency to develop invasive epidermoid carcinoma, a tendency that is enhanced by concomitant human papillomaviral infection. (Segen, Dictionary of Modern Medicine, 1992)
Synonyms: exact_synonym: Cervical Intraepithelial Neoplasia, Grade III; Cervical Intraepithelial Neoplasm; Cervical Intraepithelial Neoplasms
primary_id: MESH:D018290
Cervical Intraepithelial Neoplasia
G
Adam9
ADAM metallopeptidase domain 9
ISS
16
71,446,498
71,526,108
RGD:2325246
RGD
G
Bcl2
B-cell CLL/lymphoma 2
Disease_progression
ISS
13
12,730,736
12,905,108
RGD:2298889
RGD
G
Brca1
breast cancer 1, early onset
ISS
10
90,513,630
90,572,676
RGD:2298942
RGD
G
Cadm1
cell adhesion molecule 1
Severity
ISS
8
50,765,645
51,108,962
RGD:2289089
RGD
G
Ccnd1
cyclin D1
ISS
1
205,357,235
205,366,757
RGD:2293574
RGD
G
Ccne1
cyclin E1
ISS
1
90,568,189
90,577,426
RGD:2293574
RGD
G
Ccng1
cyclin G1
ISS
10
25,776,380
25,782,754
RGD:2316022
RGD
G
Cd46
CD46 molecule, complement regulatory protein
ISS
13
110,972,812
111,003,407
RGD:2293549
RGD
G
Cdh1
cadherin 1
ISS
19
36,442,693
36,512,091
RGD:2289490
RGD
G
Cdk4
cyclin-dependent kinase 4
Disease_progression
ISS
RGD:2293574
RGD
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
Disease_progression
ISS
4
171,841,705
171,846,506
RGD:2293574
RGD
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISS
5
108,908,749
108,916,380
RGD:2296054
RGD
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISS
5
108,908,749
108,916,380
RGD:2289675
RGD
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISS
5
108,908,749
108,916,380
RGD:2289676
RGD
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
Disease_progression
ISS
5
108,908,749
108,916,380
RGD:2296058
RGD
G
Cdkn2a_v1
cyclin-dependent kinase inhibitor 2A, variant 1
ISS
RGD:2289675
RGD
G
Cdkn2a_v1
cyclin-dependent kinase inhibitor 2A, variant 1
ISS
RGD:2289676
RGD
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
ISS
5
108,939,669
108,945,293
RGD:2289695
RGD
G
Csf1r
colony stimulating factor 1 receptor
Disease_progression
ISS
18
57,080,324
57,107,295
RGD:2299119
RGD
G
Ctnna1
catenin (cadherin-associated protein), alpha 1, 102kDa
Disease_progression
ISS
18
27,629,915
27,769,360
RGD:2289797
RGD
G
Faslg
Fas ligand (TNF superfamily, member 6)
ISS
13
77,472,950
77,480,210
RGD:2290052
RGD
G
Hdac1
histone deacetylase 1
ISS
5
148,672,515
148,699,810
RGD:2306200
RGD
G
Hdac2
histone deacetylase 2
ISS
20
41,162,093
41,186,492
RGD:2306200
RGD
G
Hdac6
histone deacetylase 6
ISS
X
26,585,852
26,606,999
RGD:2306200
RGD
G
Igfbp3
insulin-like growth factor binding protein 3
ISS
14
87,959,153
87,967,085
RGD:2290021
RGD
G
Igfbp3
insulin-like growth factor binding protein 3
ISS
14
87,959,153
87,967,085
RGD:2290004
RGD
G
Mgp
matrix Gla protein
ISS
4
173,910,595
173,913,917
RGD:2293584
RGD
G
Mlh1
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)
ISS
8
115,616,396
115,653,471
RGD:2293515
RGD
G
Mmp2
matrix metallopeptidase 2
Disease_progression
ISS
19
15,246,036
15,275,061
RGD:2290402
RGD
G
Msh2
mutS homolog 2 (E. coli)
ISS
6
11,199,906
11,258,350
RGD:2293515
RGD
G
Phb
prohibitin
ISS
RGD:2292398
RGD
G
Pten
phosphatase and tensin homolog
ISS
1
236,771,027
236,837,261
RGD:2298701
RGD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
Disease_progression
ISS
13
64,427,288
64,432,978
RGD:2299119
RGD
G
Rb1
retinoblastoma 1
ISS
15
53,828,881
53,962,099
RGD:2299896
RGD
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
Disease_progression
ISS
1
208,262,669
208,273,148
RGD:2298759
RGD
G
RT1-Db1
RT1 class II, locus Db1
ISS
20
4,671,489
4,681,058
RGD:2306230
RGD
G
RT1-Db1
RT1 class II, locus Db1
ISS
20
4,671,489
4,681,058
RGD:2306232
RGD
G
RT1-Db1
RT1 class II, locus Db1
ISS
20
4,671,489
4,681,058
RGD:2314703
RGD
G
Skp2
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
Severity
ISS
2
58,769,164
58,797,229
RGD:2315036
RGD
G
Stat3
signal transducer and activator of transcription 3 (acute-phase response factor)
Disease_progression
ISS
10
89,821,078
89,872,970
RGD:2298536
RGD
G
Stat3
signal transducer and activator of transcription 3 (acute-phase response factor)
ISS
10
89,821,078
89,872,970
RGD:2291916
RGD
G
Terc
telomerase RNA component
Disease_progression
ISS
2
117,234,446
117,234,833
RGD:2291968
RGD
G
Tert
telomerase reverse transcriptase
Disease_progression
ISS
1
30,445,180
30,465,942
RGD:2291985
RGD
G
Thrb
thyroid hormone receptor beta
ISS
15
9,282,845
9,345,506
RGD:2315099
RGD
G
Tlr9
toll-like receptor 9
Disease_progression
ISS
RGD:2301099
RGD
G
Top2a
topoisomerase (DNA) II alpha
ISS
10
87,771,337
87,800,960
RGD:2315126
RGD
G
Tp63
tumor protein p63
Disease_progression
ISS
11
76,900,622
77,200,251
RGD:2315435
RGD
G
Tp73
tumor protein p73
Disease_progression
ISS
5
170,848,979
171,078,739
RGD:2290589
RGD
G
Vegfa
vascular endothelial growth factor A
ISS
9
10,520,730
10,536,071
RGD:2315456
RGD
G
Xiap
X-linked inhibitor of apoptosis
ISS
X
3,011,520
3,047,798
RGD:2315850
RGD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest